How big is Tempest Therapeutics, Inc.?

Jun 22 2025 06:25 PM IST
share
Share Via
As of Jun 18, Tempest Therapeutics, Inc. has a market capitalization of 28.00 million and reported net sales of 0.00 million with a net profit of -44.80 million over the last four quarters. As of Dec 24, the company's shareholder's funds were 19.13 million, and total assets amounted to 44.02 million.
As of Jun 18, Tempest Therapeutics, Inc. has a market capitalization of 28.00 million, categorizing it as a Micro Cap company.

As of Jun 18, the company reported net sales of 0.00 million for the latest four quarters, with a consolidated net profit of -44.80 million during the same period.

As of Dec 24, the company's shareholder's funds were 19.13 million, and total assets amounted to 44.02 million.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
What does Tempest Therapeutics, Inc. do?
Jun 22 2025 07:15 PM IST
share
Share Via